Under 35 Changemaker Award Winner 2024 - Innovation Category
Fábio holds a double PhD degree in experimental biology and biomedicine from Lund University, Sweden, and Coimbra University, Portugal. During his research career, he developed a strong interest in deciphering how direct cell reprogramming can be used to modulate immune responses.
Fabio is passionate about entrepreneurship, and a cofounder of 2 biotech startup companies in the field of cancer immunotherapy and direct reprogramming. He participated in several acceleration programs and business competitions, and co-founded Asgard Therapeutics, a spin-off from Lund University.
Fabio has filed 5 patent applications and received over 15 different scientific and entrepreneurship awards, including selection for Forbes 30 Under 30 List for Science & Healthcare in Europe (2020) and the Maja and Hjalmar Leander Foundation Award for Best PhD thesis in Cancer Research (2022). In 2021, Fabio was appointed Head of Research at Asgard Therapeutics to lead research and development activities and mature cell reprogramming technologies for cancer immunotherapy.
Award Motivation: Fábio is a recipient of the Under 35 Changemaker Award 2024 for his groundbreaking work in immunology, paving the way for novel therapeutic approaches targeting cancer through personalized antitumor immunity, while also demonstrating true entrepreneurship drive.